Search the site

Inviting expressions of interest for the INSPIRE Consumer Reference Group (CRG) of WA – a group for the Aboriginal Children’s Excellent (ACE) Lung Health studies.

Incorporating Children's Voices

Informing urban planning and policy development to grow equitable access to healthy environments for young people and their families.

Indigenous young people's resilience and wellbeing

Carrington Shepherd PhD Honorary Research Associate Honorary Research Associate Areas of research expertise: Population health; Aboriginal and Torres

Infant and Early Childhood Sleep

Self-regulatory difficulties in infants (difficulty soothing and sleeping) tells us that the infant may be at risk of developing a range of physical and mental health difficulties in later life.

Infants entering care: developmental needs and care trajectories

Melissa O'Donnell BPsych (Hons), MPsych, GradDip Ed, PhD Honorary Research Associate Honorary Research Associate Areas of research expertise: Child

Infants removed by Child Protection: Nature, extent and impact

This study aims to increase knowledge about the nature, extent and impact of removals, repeat removals and entries of new babies into the care system.

Investigating the relationships between sun exposure and cardiometabolic dysfunction

Peter Shelley Jacoby Gorman BA (Hons) MSc BSc (Hons) PhD Biostatistician Honorary Research Associate Peter.Jacoby@thekids.org.au shelley.gorman@

Investigating the role of Neutrophils in Multiple Sclerosis

Neutrophils are a type of immune cell that can trigger inflammation and may play a role in the development of MS.

Investigation of care experiences and support associated with positive educational outcomes: evidence for improving educational trajectories for children in care

Melissa O'Donnell BPsych (Hons), MPsych, GradDip Ed, PhD Honorary Research Associate Honorary Research Associate Areas of research expertise: Child

Ivacaftor or lumacaftor/ivacaftor treatment does not alter the core CF airway epithelial gene response to rhinovirus

We tested the hypothesis that treatment of CF epithelial cells with ivacaftor (Iva) or ivacaftor/lumacaftor (Iva/Lum) would improve control of rhinovirus infection.